Clinical Trials for: sirolimus
A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects
Status: Completed Condition: Healthy Subjects; Pharmacokinetics of Isavuconazole; Pharmacokinetics of Sirolimus
Sirolimus for Autoimmune Disease of Blood Cells
Status: Recruiting Condition: Autoimmune Pancytopenia; Autoimmune Lymphoproliferative Syndrome (ALPS); Evans Syndrome; Idiopathic Thrombocytopenic Purpura; Anemia, Hemolytic, Autoimmune; Autoimmune Neutropenia; Lupus Erythematosus, Systemic; Inflammatory Bowel Disease; Rheumatoid Arthritis
RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib
Status: Completed Condition: Metastatic Renal Cell Carcinoma
Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
Status: Recruiting Condition: Advanced Cancer
Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)
Status: Recruiting Condition: Tuberous Sclerosis Complex
Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)
Status: Recruiting Condition: Hepatocellular Carcinoma
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
Zydus Pharms Usa Inc
|TABLET;ORAL||201676||Jan 8, 2014||RX||No||<disabled>||PATENT CHALLENGE|
Pf Prism Cv
|TABLET;ORAL||021110||Feb 23, 2004||DISCN||No||5,989,591*PED||<disabled>||Y|
Pf Prism Cv
|TABLET;ORAL||021110||Feb 23, 2004||DISCN||No||5,100,899*PED||<disabled>||Y|
Pf Prism Cv
|TABLET;ORAL||021110||Aug 22, 2002||RX||Yes||5,989,591*PED||<disabled>||Y|
|This preview shows a limited data set|
Complete access is available with a Subscription
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639